CPhI Show Daily Podcast Series - Valsynthese - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

CPhI Show Daily Podcast Series - Valsynthese

Valsynthese - Mr. Helmut Zimmerman

Helmut Zimmermann
Commercial Director

Add this Podcast feed to your media player

Valsynthese is a custom manufacturing organisation concentrating on hazardous and high energetic chemistry. Mr. Zimmermann introduces Valsynthese’s new capabilities in phosgenation, further expanding their tool-box of core competencies in highly energetic reactions. Mr. Zimmerman also delivers quality system updates as well as future plans for compliance beyond approval as API manufacturers in Europe, Asia, South America and Japan. Reducing environmental impact through investment in new recycling facilities is also discussed.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here